PM lays foundation stone for National Institute for One Health in Nagpur
The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents
The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents
Phase-III trials were conducted for safety, and immunogenicity in around 3,100 subjects, in 14 trial sites across India (supported by BIRAC)
It serves to leverage the strengths of various institutions to coordinate AMR surveillance lab networks
The newly built complex of RRIUM, which will be under CCRUM, the apex government organization for research in Unani Medicine
India is home to nearly 80 million diabetics and this number is expected to rise to a staggering 134 million in the next 25 years.
Phase III trial also demonstrated a statistically significant reduction (14%) in hospitalization for any cause, bringing potential relief for patients and reducing burden on healthcare systems
His experience covers a wide range of areas including advisory services in the field of accounting, taxation, corporate and commercial laws, and regulatory matters
The participants discussed the latest developments under ABDM that shall enable true interoperability in the health sector and how effective adoption of ABDM can pave the way towards Universal Health Coverage
Menon has over 41 years of diverse experience in some of the premier multinational and Indian companies in the chemical and power industry
Pluvicto and Scemblix launches are progressing well and we are awaiting data in earlier lines of therapy.
Subscribe To Our Newsletter & Stay Updated